flutamide and curcumin

flutamide has been researched along with curcumin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ram Sairam, M; Tiwari-Pandey, R1
Goto, M; Huang, R; Lee, KH; Lin, L; Morris-Natschke, SL; Ohkoshi, E; Shi, Q; Wada, K1
Culig, Z1
Chang, C; Han, R; Li, Y; Messing, E; Niu, Y; Shang, Z; Shyr, CR; Tian, J; Yeh, S; Zhang, M1

Reviews

1 review(s) available for flutamide and curcumin

ArticleYear
Targeting the androgen receptor in prostate cancer.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10

    Topics: Androgen Antagonists; Anilides; Antibodies, Neutralizing; Anticarcinogenic Agents; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Curcumin; Flutamide; Histone Deacetylase Inhibitors; HSP90 Heat-Shock Proteins; Humans; Male; Molecular Targeted Therapy; Nitriles; Oligonucleotides, Antisense; Phenylthiohydantoin; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Steroid 17-alpha-Hydroxylase; Tosyl Compounds

2014

Other Studies

3 other study(ies) available for flutamide and curcumin

ArticleYear
Modulation of ovarian structure and abdominal obesity in curcumin- and flutamide-treated aging FSH-R haploinsufficient mice.
    Reproductive sciences (Thousand Oaks, Calif.), 2009, Volume: 16, Issue:6

    Topics: Abdominal Fat; Aging; Animals; Curcumin; Female; Flutamide; Haploidy; Mice; Mice, Transgenic; Obesity; Ovary; Receptors, FSH

2009
Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.
    Bioorganic & medicinal chemistry, 2012, Jul-01, Volume: 20, Issue:13

    Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Curcumin; Drug Design; Flutamide; Humans; Male; Nitriles; Prostatic Neoplasms; Pseudopodia; Structure-Activity Relationship; Tosyl Compounds

2012
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:11

    Topics: Androgen Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cell Line, Tumor; Cell Movement; Cell Survival; Curcumin; Disease Progression; Drug Synergism; Female; Flutamide; Gene Expression; Humans; Integrin alpha5beta1; Interleukin-6; Macrophages; Mice; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Urinary Bladder Neoplasms

2015